Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CenturyCom, I'm unsure of the point that you are trying to make.
4
Nov 15, 2007 07:36AM
4
Nov 15, 2007 10:29AM
2
Nov 15, 2007 04:57PM

Nov 15, 2007 05:02PM
2
Nov 15, 2007 05:20PM

During 1 quarter 263,983 shares were sold by probably 1 institutional investor, that still left 126 institutions holding 80% of the float. One day, hopefully, PTSC will be in a similar position.

I was merely giving you one example to counter your statement that, "Institutions hate R/S" - it's not the R/S that dissuades institutional investment but Company fundamentals. Any decent Company going the R/S route will always attract institutions.

Any notion that broaching the subject is either FUD or bashing is totally specious.

 

 

Be well

5
Nov 16, 2007 03:14AM
2
Nov 16, 2007 03:54AM
1
Nov 16, 2007 04:33AM
1
Nov 16, 2007 04:38AM
4
Nov 16, 2007 04:42AM

Nov 16, 2007 04:43AM
2
Nov 16, 2007 04:44AM
1
Nov 16, 2007 04:48AM

Nov 16, 2007 04:50AM

Nov 16, 2007 04:50AM

Nov 16, 2007 04:51AM
Share
New Message
Please login to post a reply